Ingevity reported a strong first quarter in 2022, marked by record sales of $382.8 million, a 19.5% increase. Net income rose to $60.8 million, with diluted EPS at $1.55. The company has adjusted its full-year guidance, increasing the top end of the ranges to sales between $1.525 billion and $1.65 billion and adjusted EBITDA between $430 million and $470 million.
Record sales of $382.8 million, up 19.5% year-over-year.
Net income of $60.8 million and diluted earnings per share (EPS) of $1.55.
Record first quarter adjusted EBITDA of $119.0 million, up 12.9% with a margin of 31.1%.
Adjusted full year 2022 guidance increasing the top ends of the ranges to sales between $1.525 billion and $1.65 billion and adjusted EBITDA between $430 million and $470 million.
Ingevity raised the top ends of its 2022 guidance ranges to sales between $1.525 billion to $1.65 billion and adjusted EBITDA between $430 million to $470 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance